Gliptins APIs are key raw materials for the production of drugs used to treat diabetes. These APIs work by inhibiting dipeptidyl peptidase-4 (DPP-4), increasing the levels of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) in the body. This promotes insulin secretion and inhibits glucagon secretion, thus achieving the effect of lowering blood sugar. Clinically, drugs made from Gliptins APIs can be used to treat type 2 diabetes, effectively controlling blood sugar levels with a relatively low risk of hypoglycemia.
-
![CAS NO.486460-32-6-Sitagliptin Base]()
-
![Trelagliptin CAS NO.865759-25-7]()
-
![Trelagliptin Succinate CAS NO.1029877-94-8]()
Trelagliptin Succinate CAS NO.1029877-94-8Troxagliptin succinate is a hypoglycemic agent, or DPP4 inhibitor -
![Vildagliptin CAS NO.274901-16-5]()
Vildagliptin CAS NO.274901-16-5small molecule inhibitor; diabetes mellitus; phosphine ligand; weigliptin (raw material drug); protease; drug for the treatment of type 2 diabetes mellitus; weigliptin impurity WC
We're well-known as one of the leading trelagliptin apis manufacturers and suppliers in China. Our factory offers high quality trelagliptin apis made in China with competitive price. Welcome to contact us for wholesale service.
Atorvastatin Calcium, T11, Steroid Hormone Drugs Intermediates
